Merus NVNASDAQ:MRUS
- LAST PRICE52.9500
- TODAY'S CHANGE (%)-0.1400 (-0.2637%)
- Bid / Lots45.5200/ 1
- Ask / Lots52.5000/ 9
- Open / Previous Close53.1000 / 53.0900
- Day Range
- 52 Week Range
- Volume305,263
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MRUS |
|---|---|---|
| 09:32 ET | 638 | 53.1 |
| 09:34 ET | 636 | 53.25 |
| 09:36 ET | 560 | 53.37 |
| 09:45 ET | 3230 | 53.245 |
| 09:48 ET | 3154 | 52.945 |
| 09:50 ET | 300 | 53.05 |
| 09:52 ET | 100 | 52.84 |
| 09:56 ET | 100 | 53.08 |
| 09:57 ET | 100 | 52.85 |
| 09:59 ET | 3417 | 53.1575 |
| 10:01 ET | 551 | 53.32 |
| 10:03 ET | 2375 | 53.3 |
| 10:06 ET | 602 | 53.3 |
| 10:08 ET | 100 | 53.485 |
| 10:12 ET | 6404 | 53.37 |
| 10:14 ET | 15311 | 53.05 |
| 10:15 ET | 5273 | 53.045 |
| 10:17 ET | 1935 | 53.155 |
| 10:19 ET | 600 | 53.06 |
| 10:24 ET | 850 | 53.18 |
| 10:26 ET | 650 | 53.06 |
| 10:28 ET | 1881 | 52.88 |
| 10:30 ET | 1263 | 52.76 |
| 10:32 ET | 839 | 52.835 |
| 10:33 ET | 300 | 52.825 |
| 10:35 ET | 1597 | 52.835 |
| 10:37 ET | 250 | 52.8833 |
| 10:39 ET | 610 | 52.87 |
| 10:42 ET | 250 | 52.825 |
| 10:44 ET | 140 | 52.81 |
| 10:46 ET | 950 | 52.81 |
| 10:48 ET | 1646 | 52.78 |
| 10:50 ET | 600 | 52.8098 |
| 10:51 ET | 10117 | 53 |
| 10:53 ET | 900 | 52.73 |
| 10:57 ET | 500 | 52.71 |
| 11:00 ET | 1813 | 52.4 |
| 11:02 ET | 2013 | 52.53 |
| 11:04 ET | 300 | 52.55 |
| 11:08 ET | 800 | 52.46 |
| 11:09 ET | 300 | 52.42 |
| 11:11 ET | 2473 | 52.39 |
| 11:13 ET | 600 | 52.32 |
| 11:18 ET | 1339 | 52.28 |
| 11:20 ET | 100 | 52.3125 |
| 11:22 ET | 964 | 52.41 |
| 11:24 ET | 1700 | 52.22 |
| 11:27 ET | 5205 | 52.38 |
| 11:29 ET | 100 | 52.45 |
| 11:31 ET | 1825 | 52.4734 |
| 11:33 ET | 1805 | 52.54 |
| 11:36 ET | 1561 | 52.54 |
| 11:38 ET | 4225 | 52.275 |
| 11:40 ET | 200 | 52.2 |
| 11:44 ET | 600 | 52.19 |
| 11:45 ET | 3616 | 52.1875 |
| 11:47 ET | 813 | 52.215 |
| 11:49 ET | 200 | 52.24 |
| 11:54 ET | 1592 | 52.185 |
| 11:56 ET | 100 | 52.16 |
| 11:58 ET | 400 | 52.2 |
| 12:00 ET | 200 | 52.195 |
| 12:02 ET | 17430 | 52.45 |
| 12:03 ET | 4155 | 52.655 |
| 12:05 ET | 200 | 52.625 |
| 12:07 ET | 7253 | 52.46 |
| 12:09 ET | 100 | 52.535 |
| 12:12 ET | 1465 | 52.625 |
| 12:14 ET | 3966 | 52.6 |
| 12:16 ET | 1055 | 52.5727 |
| 12:18 ET | 1655 | 52.45 |
| 12:20 ET | 300 | 52.45 |
| 12:21 ET | 400 | 52.48 |
| 12:23 ET | 524 | 52.54 |
| 12:25 ET | 550 | 52.495 |
| 12:27 ET | 1150 | 52.53 |
| 12:30 ET | 1547 | 52.58 |
| 12:32 ET | 2694 | 52.68 |
| 12:34 ET | 1203 | 52.765 |
| 12:36 ET | 1100 | 52.845 |
| 12:38 ET | 1228 | 52.85 |
| 12:39 ET | 6554 | 52.84 |
| 12:41 ET | 1886 | 52.75 |
| 12:43 ET | 300 | 52.71 |
| 12:45 ET | 3348 | 52.755 |
| 12:48 ET | 1000 | 52.7 |
| 12:50 ET | 850 | 52.68 |
| 12:52 ET | 3310 | 52.73 |
| 12:54 ET | 3000 | 52.92 |
| 12:56 ET | 8576 | 52.9 |
| 12:57 ET | 7800 | 53 |
| 12:59 ET | 19238 | 52.95 |
Jul 1, 2024
Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer, from 8:00AM ET on Monday Jul 01, 2024 by Dow Jones
8:00AM ET on Monday Jul 01, 2024 by Dow JonesPress Release: Merus Appoints Fabian Zohren M.D., Ph.D., as Chief Medical Officer, from 8:00AM ET on Monday Jul 01, 2024 by Dow Jones
8:00AM ET on Monday Jul 01, 2024 by Dow Jones
Jun 28, 2024
DJ Merus Price Target Maintained With a $92.00/Share by Needham, from 5:51AM ET on Friday Jun 28, 2024 by Dow Jones
5:51AM ET on Friday Jun 28, 2024 by Dow Jones
Jun 26, 2024
DJ Merus Price Target Raised to $93.00/Share From $70.00 by Citigroup, from 12:47PM ET on Wednesday Jun 26, 2024 by Dow Jones
12:47PM ET on Wednesday Jun 26, 2024 by Dow Jones
Jun 25, 2024
DJ Merus Is Maintained at Buy by B of A Securities, from 1:28PM ET on Tuesday Jun 25, 2024 by Dow Jones
1:28PM ET on Tuesday Jun 25, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Merus NV | 3.6B | -19.4x | --- |
Crinetics Pharmaceuticals Inc | 3.5B | -11.7x | --- |
Alvotech SA | 3.7B | -5.9x | --- |
Dyne Therapeutics Inc | 3.4B | -8.6x | --- |
Immunovant Inc | 3.8B | -13.9x | --- |
Avidity Biosciences Inc | 3.9B | -12.6x | --- |
Company Information
Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The company operates in the Netherlands and United States.
Contact Information
- Headquarters
- Uppsalalaan 17, 3rd & 4th floorUTRECHT, Netherlands 3584 CT
- Phone
- ---
- Fax
- ---
Executives
- Non-Executive Independent Chairman of the Board
- Anand Mehra
- President, Chief Executive Officer, Executive Director
- Sven Lundberg
- Chief Financial Officer
- Gregory Perry
- Chief Operating Officer, General Counsel, Chief Intellectual Property Officer and Head of US Legal
- Peter Silverman
- Chief Medical Officer
- Fabian Zohren
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.6B |
|---|---|
Revenue (TTM) | $38.3M |
Shares Outstanding | 67.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.12 |
EPS | $-2.72 |
Book Value | $6.16 |
P/E Ratio | -19.4x |
Price/Sales (TTM) | 93.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -434.58% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
